the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research, with this updated edition covering chapters on A bioinformatic-driven prediction of MDA9 transcriptional variants’ roles in cancer progression and treatment, Redox, cysteines, and kinases - A triad sustaining myeloid leukemia, The RAF cysteine-rich domain: structure, function, and role in disease , Membrane Potential: a new hallmark of cancer, Recent Advances and Progress in Immunotherapy of Solid Cancers, and much more.
Other sections explore Precision Medicine: Non-Invasive Therapeutic Agent Delivery with Focused Ultrasound and Microbubbles and Anti-Cancer Activity of Capsaicin and its Analogs in Gynecological Cancers.
1. 1 Introduction - p. 2 2. 2 Compartmentalization of ROS - p. 8 3. 3 ROS, GSH and cysteines - p. 11 4. 4 Post translational modification of cysteines (PTM-CysOX) - p. 17 5. 5 Activation of the antioxidant response element proteins - p. 22 6. 6 Integration of kinase signaling, PTM and redox - p. 27 7. 7 Ros-mediated cell death - p. 42 8. 8 Discussion - p. 45 9. References - p. 68 10. Chapter Two: The RAF cysteine-rich domain: Structure, function, and role in disease - p. 69 11. Chapter Three: Membrane potential: A new hallmark of cancer - p. 91 12. Chapter Four: Recent advances and progress in immunotherapy of solid cancers - p. 111 13. Chapter Five: Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles - p. 191 14. Chapter Six: Anti-cancer activity of capsaicin and its analogs in gynecological cancers - p. 241 15. Chapter Seven: Frailty assessment in geriatric radiation oncology - p. 283 16. Chapter Eight: Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer - p. 311
the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research, with this updated edition covering chapters on A bioinformatic-driven prediction of MDA9 transcriptional variants’ roles in cancer progression and treatment, Redox, cysteines, and kinases - A triad sustaining myeloid leukemia, The RAF cysteine-rich domain: structure, function, and role in disease , Membrane Potential: a new hallmark of cancer, Recent Advances and Progress in Immunotherapy of Solid Cancers, and much more.
Other sections explore Precision Medicine: Non-Invasive Therapeutic Agent Delivery with Focused Ultrasound and Microbubbles and Anti-Cancer Activity of Capsaicin and its Analogs in Gynecological Cancers.
1. 1 Introduction - p. 2 2. 2 Compartmentalization of ROS - p. 8 3. 3 ROS, GSH and cysteines - p. 11 4. 4 Post translational modification of cysteines (PTM-CysOX) - p. 17 5. 5 Activation of the antioxidant response element proteins - p. 22 6. 6 Integration of kinase signaling, PTM and redox - p. 27 7. 7 Ros-mediated cell death - p. 42 8. 8 Discussion - p. 45 9. References - p. 68 10. Chapter Two: The RAF cysteine-rich domain: Structure, function, and role in disease - p. 69 11. Chapter Three: Membrane potential: A new hallmark of cancer - p. 91 12. Chapter Four: Recent advances and progress in immunotherapy of solid cancers - p. 111 13. Chapter Five: Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles - p. 191 14. Chapter Six: Anti-cancer activity of capsaicin and its analogs in gynecological cancers - p. 241 15. Chapter Seven: Frailty assessment in geriatric radiation oncology - p. 283 16. Chapter Eight: Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer - p. 311
